Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Thrombocythemia, Essential 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

fludarabine phosphate 63Peripheral Blood Stem Cell Transplantation 54Cyclophosphamide 52Mycophenolic Acid 43Tacrolimus 42Busulfan 42Cyclosporine 34Methotrexate 31Antilymphocyte Serum 31Whole-Body Irradiation 29Melphalan 22Radiotherapy 21Filgrastim 20Etoposide 18Cytarabine 17Cord Blood Stem Cell Transplantation 16Methylprednisolone 14Flow Cytometry 14Transplantation 11Psychiatric Rehabilitation 9Polymerase Chain Reaction 9sargramostim 8Therapeutics 8Alemtuzumab 8Thiotepa 7merphos 6Sirolimus 6Immunoenzyme Techniques 6thymoglobulin 5Vorinostat 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Congenital Abnormalities × Staining and Labeling × Lymphoid × Clear all
NCT00052520 2017-03-29

Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation

Fred Hutchinson Cancer Center

Phase 1/2 Completed
37 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡